GlassScriptPhysician profile
Michael Edward Santulli
NPI 1811077274
$4,691.82
in general payments reported to CMS, 2019-2025
18 companies · $470 in 2025
The $470 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,240 · 2020: $381 · 2021: $655 · 2022: $793 · 2023: $506 · 2024: $647 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,590 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,590.20 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,392.95 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $704.53 | 2019-2024 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $247.76 | 2019-2022 | |
| Lilly USA, LLC | $232.25 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $204.84 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $192.43 | 2019-2021 | |
| Sequel Med Tech, LLC | $182.83 | 2025 | Twiist |
| Abbott Laboratories | $125.61 | 2019-2022 | |
| Corcept Therapeutics | $75.26 | 2024 | Korlym |
| Medtronic, INC. | $72.49 | 2022-2023 | Minimed 780g |
| Merck Sharp & Dohme LLC | $68.90 | 2021 | |
| Tandem Diabetes Care, INC. | $60.06 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $51.25 | 2019 | |
| Gilead Sciences, INC. | $21.50 | 2019 | |
| Medtronic Minimed, INC. | $18.87 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Senseonics, Incorporated | $14.00 | 2019 | |
| Antares Pharma, INC. | $13.70 | 2019 | |
| Cequr Corporation | $12.59 | 2024 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Santulli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.